PMI-5011 Bioactive Fraction (Artemisia dracunculus Polyphenols)
PreliminaryMechanism of Action
Research Notes
Well-characterized animal studies by Ribnicky, Poulev, Raskin and colleagues (Phytomedicine, 2006; J Nutr Biochem, 2014) demonstrated that PMI-5011 at 500–1000 mg/kg reversed insulin resistance and reduced hyperglycemia in high-fat-diet ob/ob mice and Zucker fatty rats, with IRS-1 and Akt phosphorylation confirmed by Western blot in skeletal muscle. Two human pilot RCTs (Cefalu et al.; n=25 and n=40, respectively) found PMI-5011 (500 mg/day and 1000 mg/day) significantly improved insulin sensitivity by 18–28% (measured by hyperinsulinemic-euglycemic clamp) and reduced postprandial glucose excursions versus placebo over 4–8 weeks in metabolic syndrome patients, with no significant adverse effects. These trials are small and require replication in larger multicenter RCTs.
Found In 1 Herb
3D Molecular Structure
PMI-5011 Bioactive Fraction (Artemisia dracunculus Polyphenols)
Representative pattern: C₁₅H₁₀O₃
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
